中药灵芝降羊毛甾烷三萜类成分研究

研究灵芝Ganoderma lingzhi子实体的化学成分。采用正相硅胶、ODS、Sephadex LH-20凝胶柱色谱和prep-HPLC等方法分离与纯化,运用NMR、MS等波谱技术鉴定化合物结构。从灵芝95%乙醇提取物中分离得到5个降羊毛甾烷三萜类化合物,分别是ethyl 20(21)-dehydrolucidenate A(1)、lingzhi-20(21)-en-24-oic acid A(2)、20(21)-dehydrolucidenic acid A(3)、赤芝酮A(4)、lucidadone H(5)。化合物1和2是两个新的降羊毛甾烷三萜化合物;化合物3~5为首次从该属真菌中分离得到。化合物1和2在白血病(HL-60)、肺癌(A549)、肝癌(SMMC-7721)、乳腺癌(MCF-7)、结肠癌(SW480)五种不同的癌细胞株上进行细胞毒活性筛选,结果显示化合物1~5在40μM时无明显的细胞毒活性。     

灵芝深层发酵生产四环三萜酸的研究

从灵芝深层发酵产物中分离得到三种四环三萜酸,命名为灵芝酸Ｍ１,Ｍ２,Ｍ３,在２５Ｌ发酵罐上研究了发酵条件对灵芝酸产量的影响,以及灵芝酸的代谢形成特征。结果表明最适发酵条件是：温度３０℃;通风量１：０．７５ｖ／ｖ／ｍ;搅拌转速１８０ｒ／ｍｉｎ;发酵时间８０ｈ,此时灵芝酸的最高产量是０．３６ｇ／Ｌ发酵液。抑菌实验表明上述灵芝酸能够抑制大肠杆菌,产气杆菌、肠炎杆菌、金黄色葡萄球菌和枯草芽孢杆菌的生长。     

9,10-环甲基十七烷酸干预下灵芝深层发酵合成三萜酸的动力学特征

利用Sigmoid模型对比研究了添加9,10-环甲基十七烷酸（9,10-CMA）前后灵芝深层发酵产三萜酸的动态变化特征。研究显示,灵芝对照组中三萜酸在4-9d大量合成,并于第9天达到最大值（268.62mg/L）;添加9,10-CMA组中三萜酸的合成量于第8天时达到最大值（343.52mg/L）。添加9,10-CMA后,灵芝菌丝体细胞对底物葡萄糖的利用速度加快,细胞比生长速率在3.2天达到最大值（Μ_max）,为0.94d ^-1,显著高于对照组的0.88d ^-1（在第3.4天获得）;葡萄糖比消耗速率在第1.7天达到最大值（Q_{S, max}）,为8.34d ^-1,显著高于对照组的6.80d ^-1（在第2.1天获得）。胞内三萜酸比合成速率显著提高,在第6.2天达到最大值（Q_{ITA, max}）13.76d ^-1,是对照组9.66d ^-1的1.42倍。两组中灵芝三萜酸的合成与细胞生长均呈现部分偶联关系,添加9,10-CMA后,没有改变细胞生长和三萜酸合成在发酵过程中的相互关系。     

两株多孔菌属担子菌菌丝体中的三萜成分

用组织分离法从采集于广东鼎湖山的2株多孔菌属担子菌子实体中分离得到2株菌丝体,并对菌丝体分别进行固体发酵培养,培养物经乙醇提取后,用柱层析分离得到4个化合物,用光谱法鉴定均为羊毛脂烷型三萜,它们分别是多孔菌酸C（polyporenic acid C）（1）、茯苓酸（pachymic acid）（2）、齿孔酸（eburicoic acid）（3）和硫磺菌酸（sulphurenic acid）（4）。其中化合物2为首次从多孔菌属中发现。     

9,10-环甲基十七烷酸诱导灵芝三萜酸合成的信号转导和基因表达分析

为探究9,10-环甲基十七烷酸（9,10-CMA）诱导灵芝三萜酸合成的相关信号机制,分析了NO信号的介导作用。结果表明,在NO信号分子介导下,9,10-CMA可有效地刺激灵芝菌丝体中三萜合成关键酶细胞色素CYP450和苯丙氨酸解氨酶（PAL）的活化以及三萜酸的合成。NO可作为灵芝菌丝体中CYP450产生和PAL活化的上游分子发挥作用。在9,10-CMA诱导下,通过荧光定量PCR分析了6个关键酶基因在灵芝三萜酸合成过程的动态表达。结果表明,在9,10-CMA诱导下与灵芝三萜酸合成相关的角鲨烯合成酶基因sqs、细胞色素P450单加氧酶CYP5150L8基因和3‐羟基‐3‐甲基戊二酰辅酶A还原酶基因hmgr的上调最显著,提示这3个酶在三萜诱导过程中具有重要作用。     

层迭灵芝子实体的体外抗肿瘤及免疫活性

【背景】层迭灵芝Ganoderma lobatum是灵芝属中的一个种,在民间有药用历史,但缺乏对其化学成分和药理活性的科学研究。【目的】以赤芝Ganoderma lingzhi子实体为参照,研究对比层迭灵芝子实体的抗肿瘤及免疫活性的强弱,探讨层迭灵芝的药用价值。【方法】采用化学分析及仪器分析的方法,比较2种灵芝子实体中三萜及多糖含量差异,并进行体外抗肿瘤及免疫活性研究。【结果】层迭灵芝和赤芝的子实体中三萜含量差异不大,分别为1.14%和1.21%,但2种灵芝中三萜化合物的种类差异较大。层迭灵芝子实体中的多糖含量较赤芝稍高,分别为3.60%和2.67%,2种子实体中多糖的重均分子量分布特征有所差别。2种灵芝醇提物对肿瘤细胞K562及SW620的增殖均具有一定的抑制活性,其中,层迭灵芝对SW620细胞具有较强的抑制活性,其IC50值达到了52.5μg/mL。2种灵芝水提物可以促进RAW 264.7细胞释放NO,说明两者均具有一定的免疫活性。【结论】层迭灵芝具有较好的抗肿瘤及免疫活性,可以作为药用开发的原料来源。     

灵芝子实体和孢子粉三萜含量的测定及体外抗肿瘤活性的评价

目的测定灵芝子实体和破壁灵芝孢子粉中的三萜含量,并评价其醇提物的体外抗肿瘤活性。方法采用高氯酸显色法测定灵芝子实体和破壁灵芝孢子粉中的三萜含量,采用磺酰罗丹明B蛋白染色法(sulforhodamine B,SRB)评价灵芝子实体和破壁灵芝孢子粉醇提物对宫颈癌He La细胞、结肠癌HCT-116细胞和乳腺癌MCF-7-ADM细胞的体外抗肿瘤活性。结果研究的灵芝子实体中三萜质量分数为0.92%,破壁灵芝孢子粉供试品中三萜质量分数实测值为2.95%,但是灵芝孢子粉中脂肪油对高氯酸显色法有极大的干扰,因此破壁灵芝孢子粉三萜的实测值可能远高于实际值。活性评价结果显示,灵芝子实体的醇提物在100μg/m L时,其对人宫颈癌He La细胞和乳腺癌MCF-7-ADM细胞表现出了较强的抑制作用,抑制率分别为94.54%和71.30%;对结肠癌HCT-116细胞表现出较弱的抑制作用,抑制率为20.68%。破壁灵芝孢子粉的醇提物在100μg/m L和10μg/m L时,其对宫颈癌He La细胞表现出了弱的抑制作用,对另外2种细胞系仅在100μg/m L时表现出较弱的抑制作用。结论灵芝子实体的醇提物含有三萜并具有较好的抗肿瘤活性,可以将其开发为辅助治疗癌症的药物或保健品。含有脂肪油的灵芝孢子粉直接采用高氯酸比色法测定会高估其三萜的含量,需要进一步开发准确、可行的测定方法。     

药用大型真菌灵芝中的三萜酸类成分研究

目的对灵芝中的三萜类成分进行结构与活性研究。方法通过氯仿对灵芝新鲜子实体的乙醇提取物进行萃取,进一步通过硅胶柱层析、中压液相(ODS色谱柱)、制备型HPLC对氯仿提取物中的化学成分进行分离、纯化。通过UV、ESI-MS、HRESI-MS、~1H-NMR、~(13)C-NMR、HSQC、HMBC、NOESY等光谱技术对所分离得到的化合物进行准确的结构鉴定。通过α-葡萄糖苷酶抑制模型对所分离得到的三萜类化合物进行活性评价。结果从灵芝子实体中分离鉴定了7个三萜类成分,分别为:(1)Ganoderic acid X1,(2)Ganoderic acid C,(3)Deacetyl-ganoderic acid F,(4)Ganoderic B,(5)Lucienic acid A,(6)7-hydroxy-3,11,15-trioxo-lanosta-8-en-24→20sLactone,(7)Methyl lucidenate D2。化合物1和6显示了一定的α-葡萄糖苷酶抑制活性。结论灵芝中的主要化学成分类型为羊毛脂烷型三萜及其降碳衍生物,其中化合物1为未见报道的新化合物。该类成分显示了一定的α-葡萄糖苷酶抑制作用,具有较好的研究前景。     

硬孔灵芝的化学成分研究

采用硅胶柱层析法进行分离纯化,从硬孔灵芝Ganoderma duropora的氯仿萃取物中分离得到甾类化合物8种。根据波谱数据,化合物1-8结构分别被鉴定为:麦角甾醇、麦角甾-7,22-二烯-3β-醇、麦角甾-7,22-二烯-3-酮、6,9-环氧麦角甾-7,22-二烯-3β-醇、过氧麦角甾醇、3,5-二羟基麦角甾-7,22-二烯-6-酮、β-谷甾醇和胡萝卜苷。     

荷叶离褶伞子实体化学成分

本文对祁连山野生荷叶离褶伞Lyophyllum decastes子实体的化学成分和生物活性进行研究。采用硅胶色谱、高效液相色谱等多种方法进行分离纯化得到8个化合物,通过MS、NMR和电子圆二色谱 （ECD）等方法确定了化学结构,其中有4个为聚炔类化合物。化合物1作为天然产物系首次报道,其相绝对构型是通过比较ECD的方法确定。对所得聚炔类化合物应用细胞模型进行抗氧化活性（CAA）指标检测,化合物1-4均呈现一定抗氧化活性,其中化合物1的抗氧化活性最强,其EC₅₀为(24.73±6.12)μmol/L。聚炔类化合物1-4为荷叶离褶伞首次报道成分,可作为祁连山野生荷叶离褶伞HPLC-DAD化学表征参考化合物。     

Meroterpenoids from the fruiting bodies of higher fungus Ganoderma resinaceum

Phytochemical investigation on the fruiting bodies of Ganoderma resinaceum led to the isolation of five new meroterpenoids, namely ganoresinains A–E (1–5), and four known analogues (6–9). The new compounds were identified by extensive analyses of spectroscopic data (NMR, MS, UV, and IR) and comparison with the literature data. Compound 1 and 6 were isolated as enantiomeric mixture, which were separated over analytical chiral HPLC chromatography. Compounds 6–9 were isolated from G. resinaceum for the first time.     

A new nortriterpenoid from the fruiting bodies of Ganoderma tropicum

Ganoderma tropicum has been widely used by the local folks for coronary heart disease treatment, liver protection, and sleep aid. In order to discover natural active components and tap the medical potential of G. tropicum, the chemical investigation of its fruiting bodies was carried out. This study led to the isolation of a new nortriterpenoid named 26-nor-11,23-dioxo-5α-lanost-8-en-3β,7β,15α,25-tetrol (1) and a known nortriterpenoid lucidone D (2). The structure of the new nortriterpenoid was elucidated by spectroscopic techniques including UV, IR, MS, 1D and 2D NMR spectroscopy.     

Two new nortriterpenoids from the fruiting bodies of Ganoderma daqingshanense

Two new nortriterpenoids named daqingshones A (1) and B (2), along with two known ganderic acids (3 and 4), were isolated from the fruiting bodies of Ganoderma daqingshanense. Their structures were elucidated by spectroscopic data including MS, 1D and 2D NMR. Compound 2 exhibited weak anti-acetylcholinesterase (AChE) activity with IC₅₀ value of 39.2 μM.     

Plant growth regulators from the fruiting bodies of Tricholoma flavovirens

A novel indole derivative (1) and three known compounds (2–4) were isolated from the fruiting bodies of Tricholoma flavovirens. Their structures were determined or identified by the interpretation of spectroscopic data. Compounds 1 and 2 promoted root growth of lettuce and inhibited hypocotyl growth at 1 μmol/paper. Compound 3 inhibited hypocotyl and root growth at 100 nmol/paper.     

Isolation of the chitin-glucan complex from the fruiting bodies of mycothallus

A four-stage procedure for the isolation of the ChGC from the biomass of natural fungi—the honey mushroom (Armillariella mellea) and the yellow morel (Morchella esculenta), belonging to the classes Basidiomycetes and Ascomycetes, respectively, has been developed. The isolation procedure included deproteinization (2% NaOH + 0.1% sodium stearate, 83–85°C, 2 h), demineralization (1% HCl, 55–60°C, 2 h), depigmentation (5% H₂O₂ in ammonia (30–35°C, 4 h)), and deglucanization (2% NaOH, 83–85°C, 2 h). The original raw material and the chitin-containing materials were characterized on the basis of results of Fourier transform infrared spectroscopy, X-ray analysis, and pyrolytic gas chromatography using crustacean chitin as a reference compound. The content of chitin in the final products was 70% for A. mellea and 50% for M. esculenta. The possibility of obtaining chitin-containing materials with the required properties by selecting the fungal species and treatment conditions (the succession and repetition of certain stages) is demonstrated.     

Germination of myxospores from the fruiting bodies of Myxococcus xanthus.

Germination of myxospores from fruiting bodies of Myxococcus xanthus was examined under a light microscope as well as by analyzing the incorporation of [3H]uracil into the RNA fraction. Efficient germination was observed in 0.2% Casitone containing 8 mM MgSO4 and 1 mM CaCl2 at 30 degrees C. Under this condition, spherical myxospores were converted into rod-shaped vegetative cells within 5 to 6 h. The germination was severely inhibited in the presence of 1 mM phenylmethylsulfonyl fluoride, a protease inhibitor, indicating that a serine protease(s) is required for the myxospore germination. EGTA (1 mM) also completely blocked germination, indicating that Ca2+ plays an important role in myxospore germination. In 1% Casitone without added Mg2+ and Ca2+ or 0.2% Casamino Acids with 8 mM MgSO4 and 1 mM CaCl2, myxospores lost their refractility under a phase microscope, while no RNA synthesis took place within 6 h, as judged by the incorporation of [3H]uracil. A group of proteins were found to be specifically synthesized during an early stage of germination. In addition, a new major spore-associated protein with a size of 41.5 kDa became detectable in the spore shell fraction 3 h after germination. The present results demonstrate that myxospore germination occurs in at least two steps: the loss of myxospore refractility, followed by an outburst of metabolic activities. The first step can occur even in the absence of energy metabolism, while the second step was blocked by rifampin, EGTA, and protease inhibitors.     

Novel compounds from the mycelia and fruiting bodies of Climacodon septentrionalis

A novel ester (1) along with a known compound (2) were isolated from the mycelia of Climacodon septentrionalis. A novel furanone (3) and a known compound (4) were purified from the fruiting bodies of the fungus. The respective structures of 1 and 3 were determined as those of (S)-3-p-tolylbutyl 2-hydroxy-2-methylpropanoate and (-)-5-hydroxy-3,4-dimethyl-5-pentylfuran-2(5H)-one by interpreting the spectroscopic data.     

New xanthine oxidase inhibitors from the fruiting bodies of Tyromyces fissilis

Excessive uric acid production, which causes gout and hyperuricemia, can be blocked by inhibiting xanthine oxidase (XO). However, some agents to block on XO often cause side effects, thereby necessitating the identification of new inhibitors. During the screening of XO inhibitors from various mushroom extracts, we found that a methanolic extract of the fruiting bodies of Tyromyces fissilis, an inedible and non-toxic fungus, showed inhibitory activity. Both n-hexane and ethyl acetate layers, obtained by partitioning this extract exhibited XO inhibitory activity. Subsequently, using an activity-guided separation method, eight active compounds (1–8) were isolated. The structures of five of the new compounds, 2–4, 6, and 7, were elucidated by spectral analysis and chemical derivatization. All compounds had a salicylic acid moiety with an aliphatic group at the C-6 position. Notably, 2-hydroxy-6-pentadecylbenzoic acid (1) showed the highest level of XO noncompetitive inhibition (58.9 ± 2.2% at 25 µM).